FDA Inspection 1035451 — University Of Utah Cell Therapy And Regenerative Medicine
The FDA completed an inspection of University Of Utah Cell Therapy And Regenerative Medicine on Nov 15, 2017 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 15, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Salt Lake City, UT (United States)